亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Small molecule inhibitor for more precise biotin/streptavidin tagging affords improved live cell imaging

總結
Milan Stojanovic, Ph.D.
技術優勢
Significantly faster and cheaper method to produce monovalent streptavidin than other strategiesHighly compatible with nearly all commercially-available labeled or modified streptavidinImproves spatial resolution allowing usage in super resolution imaging methodsOligonucleotide backbone can be fully customizedInteractions with oligonucleotide backbone act as conditional switch that can free up one binding siteInhibitor itself can be tagged or labeled, if desiredPatent information:Patent Pending (WO/2013/036826Tech Ventures Reference: IR 2927
技術應用
Improves biotin labeling for live-cell imaging by blocking crosslinkingCreates simple one-to-one biotin/streptavidin complex which simplifies analysisAllows biotin labeling to be used for direct counting quantificationImprovement of a biotin immobilization strategySensitive detection of RNA or DNABlock strategy can also be used to make smaller inhibitor that produces divalent streptavidin
詳細技術說明
Milan Stojanovic, Ph.D.
*Abstract
None
*Inquiry
Jerry KokoshkaColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
2927
*Principal Investigation
*Publications
S.K. Taylor, J. Wang, N. Kostic, M. N. Stojanovic. Monovalent Streptavidin that Senses Oligonucleotides. Angewandte Chem. Int. Ed., Vol. 52, Issue 21, May 2013, pp. 5509-5512.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備